From: Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
Day 1 | Day 3 | Day 7 | Day 18 | Day 30 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
rhEPO | Placebo | rhEPO | Placebo | rhEPO | Placebo | rhEPO | Placebo | rhEPO | Placebo | |
Hematocrit (%) | 43.10 ± 0.90 | 42.70 ± 1.39 | 41.70 ± 1.00 | 40.20 ± 1.27 | 41.40 ± 1.46 | 38.00 ± 1.91 | 41.80 ± 1.23 | 38.60 ± 1.61 | 42.00 ± 1.06 | 40.50 ± 1.25 |
Red blood cell count (106/µl) | 4.80 ± 0.12 | 4.70 ± 0.16 | 4.60 ± 0.11 | 4.40 ± 0.13 | 4.50 ± 0.16 | 4.20 ± 0.22 | 4.60 ± 0.15 | 4.20 ± 0.19 | 4.70 ± 0.14 | 4.40 ± 0.16 |
Thrombocyte count (×103/µl) | 226.20 ± 14.12 | 213.50 ± 11.69 | 218.00 ± 15.56 | 218.90 ± 14.14 | 243.20 ± 19.78 | 239.40 ± 13.17 | 344.50 ± 26.61 | 362.30 ± 39.46 | 246.40 ± 19.62 | 282.10 ± 20.76 |
Serum EPO* (U/l) | 10.60 ± 1.58 | 12.00 ± 1.09 | 5148.40 ± 1094.64 | 19.50 ± 2.75 | 24.40 ± 4.37 | 31.60 ± 12.59 | 8.00 ± 1.00 | 28.50 ± 11.73 | 14.90 ± 3.56 | 21.00 ± 5.64 |